28 September 2025 - Big Pharma has a big headache: Donald Trump. Lately drugmakers have had to contend with the American president’s pronouncements on everything from vaccines to paracetamol. 

In the coming days the pain is set to intensify. Intent on lowering prices, Mr Trump has given leading pharma firms until 29 September to comply with an executive order to peg their prices to the lowest charged in other rich countries—a rule he calls “most favoured nation” pricing. If they do not, he thundered, they will face “every tool in our arsenal” against “abusive drug pricing”.

Read The Economist article